10 results match your criteria: "Centre for Precision Therapeutics[Affiliation]"
Genet Med
September 2024
Center for Applied and Translational Genomics, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, UAE; GenomeArc Inc., Mississauga, ON, Canada; College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE. Electronic address:
Front Genet
March 2023
College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
Copy number variations (CNVs) play a critical role in the pathogenesis of neurodevelopmental disorders (NDD) among children. In this study, we aim to identify clinically relevant CNVs, genes and their phenotypic characteristics in an ethnically underrepresented homogenous population of Bangladesh. We have conducted chromosomal microarray analysis (CMA) for 212 NDD patients with male to female ratio of 2.
View Article and Find Full Text PDFOphthalmol Sci
June 2022
Biomedical Sciences Research Institute, School of Biomedical Sciences, Ulster University, Coleraine, United Kingdom.
Purpose: To evaluate the therapeutic benefit of a novel peptide, ALM201, in ocular pathologic vascularization.
Design: Experimental study in mouse, rat, and rabbit animal models.
Participants: Ten-week-old Lister Hooded male rats, 8-week-old Brown Norway male rats, 9-day-old C57BL/6J mice, and 12-month-old New Zealand male rabbits.
J Invest Dermatol
December 2021
Department of Dermatology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA. Electronic address:
Despite thousands of reported patients with pandemic-associated pernio, low rates of seroconversion and PCR positivity have defied causative linkage to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Pernio in uninfected children is associated with monogenic disorders of excessive IFN-1 immunity, whereas severe COVID-19 pneumonia can result from insufficient IFN-1. Moreover, SARS-CoV-2 spike protein and robust IFN-1 response are seen in the skin of patients with pandemic-associated pernio, suggesting an excessive innate immune skin response to SARS-CoV-2.
View Article and Find Full Text PDFJ Autism Dev Disord
July 2021
College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE.
This study explored the physical and clinical phenotype of Bangladeshi children with autism spectrum disorder (ASD). A totally of 283 children who were referred for screening and administered Module 1 of the Autism Diagnostic Observation Schedule (ADOS) were included. Overall, 209 met the ADOS algorithmic cutoff for ASD.
View Article and Find Full Text PDFTissue Eng Part C Methods
October 2019
Fischell Department of Bioengineering, University of Maryland, College Park, Maryland.
Three-dimensional (3D) culture models better recapitulate the tissue microenvironment, and therefore may provide a better platform to evaluate therapeutic effects on adhesive cell-cell interactions. The objective of this study was to determine if AD-01, a peptide derivative of FK506-binding protein like that is reported to bind to the adhesion receptor CD44, would induce a greater reduction in breast epithelial spheroid adhesion to endothelial tube-like networks in our 3D coculture model system compared to two-dimensional (2D) culture. MCF10A, MCF10A-NeuN, MDA-MB-231, and MCF7 breast epithelial cells were pretreated with AD-01 either as single cells or as spheroids.
View Article and Find Full Text PDFACS Med Chem Lett
March 2018
Almac Discovery Ltd., Centre for Precision Therapeutics, 97 Lisburn Road, Belfast, Northern Ireland BT9 7AE, United Kingdom.
Ubiquitin specific protease 7 (USP7, HAUSP) has become an attractive target in drug discovery due to the role it plays in modulating Mdm2 levels and consequently p53. Increasing interest in USP7 is emerging due to its potential involvement in oncogenic pathways as well as possible roles in both metabolic and immune disorders in addition to viral infections. Potent, novel, and selective inhibitors of USP7 have been developed using both rational and structure-guided design enabled by high-resolution cocrystallography.
View Article and Find Full Text PDFMol Cancer Ther
June 2018
Drug Resistance Group, Centre for Cancer Research and Cell Biology, School of Medicine, Dentistry and Biomedical Science, Queen's University Belfast, Belfast, United Kingdom.
mutations occur in ∼10% of colorectal cancer cases, are associated with poor survival, and have limited responses to BRAF/MEK inhibition with or without EGFR inhibition. There is an unmet need to understand the biology of poor prognostic MT colorectal cancer. We have used differential gene expression and pathway analyses of untreated stage II and stage III MT (discovery set: = 31; validation set: = 26) colorectal cancer, and an siRNA screen to characterize the biology underpinning the MT subgroup with poorest outcome.
View Article and Find Full Text PDFNat Chem Biol
February 2018
Almac Discovery Ltd, Centre for Precision Therapeutics, Belfast, Northern Ireland, UK.
Given the importance of ubiquitin-specific protease 7 (USP7) in oncogenic pathways, identification of USP7 inhibitors has attracted considerable interest. Despite substantial efforts, however, the development of validated deubiquitinase (DUB) inhibitors that exhibit drug-like properties and a well-defined mechanism of action has proven particularly challenging. In this article, we describe the identification, optimization and detailed characterization of highly potent (IC < 10 nM), selective USP7 inhibitors together with their less active, enantiomeric counterparts.
View Article and Find Full Text PDFACS Chem Biol
December 2017
Oncology, IMED Biotech Unit, AstraZeneca , Cambridge, United Kingdom.